pectoral’ Partners - For New InvestorsForget the bashing nonsense and wrap your head around the 40 cent share price in the context of Spectral's partners detailed below:
Baxter- North American Commercialization partner for their PMX sepsis treatment
Infomed of Switzerland - Manufacturers of the Paradigm Shifting Sami and DIMI dialysis units, for which Spectral has 100% NA marketing rights
Estor - European distributor on EAA
Toray Medical of Japan- a major Japanese pharma which has granted Spectral the North American rights to the PMX Sepsis treatment
15 Household Brand Name US hospitals confucting the current Confirmatory PMX Sepsis treatment trial.
Da Vita - "The name" in dialysis treatment! Soon to be announced as the partner for the DIMI home use trial.
ARC Dialysis -Thrir first commercialization partner for SAMI and the largest dialysis provider in the South Eastern US
University of Michigan - DIMI home use partner and the first adopter of the fully FDA approved SAMI
The Food And Drug Administration!!!- Yes Sir - There is an enormous need for PMX and they have acknowledged that throughout the trial process and have held Spectral's hand all the way through this trial process. Breakthrough Therapy is the most recent exemple of the FDA's commitment to guiding Spectral to PMX approval for the treatment of Sepsis.
Wrap your head around that in the context on a 40 cent share price.
Maybe now you'll understand why I have been buying with both hands for nearly 2 decades!!!